HC Wainwright & Co. Reiterates Buy on GlycoMimetics, Maintains $8 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Edward White reiterates a Buy rating on GlycoMimetics (NASDAQ:GLYC) and maintains an $8 price target.
June 15, 2023 | 4:14 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. analyst Edward White reiterates a Buy rating on GlycoMimetics and maintains an $8 price target.
The reiterated Buy rating and maintained $8 price target by HC Wainwright & Co. analyst Edward White indicates a positive outlook for GlycoMimetics. This news is likely to have a positive impact on the stock price in the short term as it shows confidence in the company's potential.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100